Trial Profile

A Phase II trial of LMP400 in pediatric patients with Ewing's sarcoma

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 22 May 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Indotecan (Primary)
Indications Ewing's sarcoma
Focus Therapeutic Use
Sponsors Gibson Oncology

Most Recent Events

22 May 2019 New trial record
05 Dec 2018 According to a Gibson Oncology media release, the company intend to conduct this trial and will employ a recently discovered biomarker called Schlafen11 to select pediatric patients most likely to respond.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com